Significant publications in diabetes pharmacotherapy and technology in 2020

IF 2.7 Q3 ENDOCRINOLOGY & METABOLISM Expert Review of Endocrinology & Metabolism Pub Date : 2023-03-06 DOI:10.1080/17446651.2023.2187618

Jennifer N. Clements, Rachel Franks, Diana Isaacs, Kevin Malloy, Lisa T. Meade, Sara (Mandy) Reece, Debra J. Reid, Eileen D. Ward

{"title":"Significant publications in diabetes pharmacotherapy and technology in 2020","authors":"Jennifer N. Clements, Rachel Franks, Diana Isaacs, Kevin Malloy, Lisa T. Meade, Sara (Mandy) Reece, Debra J. Reid, Eileen D. Ward","doi":"10.1080/17446651.2023.2187618","DOIUrl":null,"url":null,"abstract":"Introduction The most significant articles on diabetes pharmacotherapy and technology in the peer-reviewed literature from 2020, as determined by a panel of pharmacists with expertise in diabetes care and education, are summarized.Areas covered Members of the Association of Diabetes Care and Education Specialists Pharmacy Community of Interest were selected to review articles published in prominent peer-reviewed journals in 2020 that most impacted diabetes pharmacotherapy and technology. A list of 37 nominated articles were compiled (22 in diabetes pharmacotherapy and 15 in diabetes technology). Based on discussion among the authors, the articles were ranked based on significant contribution, impact, and diversity to diabetes pharmacotherapy and technology. The top 10 highest ranked publications (n=6 for diabetes pharmacotherapy and n=4 in diabetes technology) are summarized in this article.Expert opinion With the significant number of publications in diabetes care and education, it can be challenging and overwhelming to remain current with published literature. This review article may be helpful in identifying key articles in diabetes pharmacotherapy and technology from the year 2020.","PeriodicalId":12107,"journal":{"name":"Expert Review of Endocrinology & Metabolism","volume":"1 1","pages":"0"},"PeriodicalIF":2.7000,"publicationDate":"2023-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Endocrinology & Metabolism","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/17446651.2023.2187618","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction The most significant articles on diabetes pharmacotherapy and technology in the peer-reviewed literature from 2020, as determined by a panel of pharmacists with expertise in diabetes care and education, are summarized.Areas covered Members of the Association of Diabetes Care and Education Specialists Pharmacy Community of Interest were selected to review articles published in prominent peer-reviewed journals in 2020 that most impacted diabetes pharmacotherapy and technology. A list of 37 nominated articles were compiled (22 in diabetes pharmacotherapy and 15 in diabetes technology). Based on discussion among the authors, the articles were ranked based on significant contribution, impact, and diversity to diabetes pharmacotherapy and technology. The top 10 highest ranked publications (n=6 for diabetes pharmacotherapy and n=4 in diabetes technology) are summarized in this article.Expert opinion With the significant number of publications in diabetes care and education, it can be challenging and overwhelming to remain current with published literature. This review article may be helpful in identifying key articles in diabetes pharmacotherapy and technology from the year 2020.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

2020年糖尿病药物治疗和技术方面的重要出版物

本文总结了由具有糖尿病护理和教育专业知识的药剂师小组确定的2020年同行评议文献中关于糖尿病药物治疗和技术的最重要文章。选定糖尿病护理和教育专家协会药学兴趣社区的成员，对2020年发表在著名同行评议期刊上的对糖尿病药物治疗和技术影响最大的文章进行审查。编制了37篇提名文章的清单(22篇关于糖尿病药物治疗，15篇关于糖尿病技术)。根据作者之间的讨论，根据对糖尿病药物治疗和技术的重大贡献、影响和多样性对文章进行排名。本文总结了排名前10位的出版物(糖尿病药物治疗n=6，糖尿病技术n=4)。专家意见随着糖尿病护理和教育方面的出版物数量的增加，跟上已发表的文献是一项挑战和压倒性的挑战。这篇综述文章可能有助于识别2020年以来糖尿病药物治疗和技术的关键文章。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Expert Review of Endocrinology & Metabolism ENDOCRINOLOGY & METABOLISM-

CiteScore

4.80

自引率

0.00%

发文量

期刊介绍： Implicated in a plethora of regulatory dysfunctions involving growth and development, metabolism, electrolyte balances and reproduction, endocrine disruption is one of the highest priority research topics in the world. As a result, we are now in a position to better detect, characterize and overcome the damage mediated by adverse interaction with the endocrine system. Expert Review of Endocrinology and Metabolism (ISSN 1744-6651), provides extensive coverage of state-of-the-art research and clinical advancements in the field of endocrine control and metabolism, with a focus on screening, prevention, diagnostics, existing and novel therapeutics, as well as related molecular genetics, pathophysiology and epidemiology.